CHEMOTHERAPY DISPENSING

Size: px
Start display at page:

Download "CHEMOTHERAPY DISPENSING"

Transcription

1 CHEMOTHERAPY DISPENSING AUTOMATION: THE TAIWANESE EXPERIENCE 1 Sarah Lo MS, BCOP Oncology Pharmacy, Department of Pharmacy National Taiwan University Hospital Taipei, Taiwan.

2 2 BACKGROUND National Taiwan University Hospital: tertiary medical center, over 2,500 beds in total. Chemotherapy dispensing unit delivers >300 doses/day Increasing work load and stringent safety requirements prompted a search for automation devices. Evaluation began in Decrease occupational hazard, increase dosing accuracy Relieve pharmacists of dispensing work Save cost on protective equipment

3 3 CYTOCARE First automated processor specialized for chemotherapy dispensing in a sterile environment. Meets ISO Class 5 clean room standard. Manufactured by Health Robotics (Bolzano, Italy)

4 4 CYTOCARE 1. Multi-axis robotic arm 2. Loading carousel 3. Computer area 4. Air treatment unit 5. Waste bin (automatic seal)

5 5 Robotic arm Vial stand Syringe holder Scale Shaker

6 6 CYTOCARE Management software (Cytoplan) Barcode label printer Error rate of dose <2.5% (<0.5% for a 20 ml dose according to manufacturer s data)

7 7 INSTALLATION AND INITIATION Dispensing room refurbished to make room for Cytocare and associated equipment Installation of robot began in late 2009 Installation, programming, staff education and testing took around 6 months

8 8 INSTALLATION AND INITIATION Workflow analysis: for work days. Selecting drugs Vials only Solutions: Fluorouracil, etoposide, carboplatin, methotrexate Lyophilized powders: cyclophosphamide, epirubicin Establishing drug profiles Photographic identification Vial measurements Specific gravity of drug solutions

9 9 INSTALLATION AND INITIATION Syringes: programmed 3 sizes Needles: non-coring vented needle On-site engineer: trained at Bolzano site Order entry: by operating pharmacist, into Cytoplan Definition of failure: Self-detected difference of >5% between product and prescribed dose Alerts operating pharmacist

10 10

11 11

12 12 PERFORMANCE First 2 months Data from May 4 th to July 9 th, 2010 (first 10 weeks of formal operation) Operated on 47 days (94% of working days) Total doses: 1028, increased as pharmacists become more familiar with robot. Maximum doses in a single day: 47 doses.

13 13 WH Chen, el al. J Formos Med Assoc 2013; 112:

14 14

15 15 REASONS FOR FAILURE Air failure: Air drawn into syringe, resulting in doses with errors of over 5% (79.7% of all failed doses) Syringe quality More vials used per dose the worse. Other failures: Loading failure (Manual): failure to load syringe/needle properly. Decreases with practice Clamp failure (mechanical)

16 16 PERFORMANCE The year after installation (2011) doses per work day Success rate 96.4% (Range %) Mechanical failure, especially clamp positioning, is major reason for failure.

17 17

18 18

19 19 LATER YEARS Stable through Best at 80 syringes/day Clamp positioning failures put operation on hold in late 2014, fixed in 2015 Breaking of clamp in Sep 2015, operation suspended until new clamp installed in 2017.

20 DAILY AVERAGE Daily Average Doses Hardware failure: clamp break on Sep 30 th, Clamp positioning issues, repair and reprogramming

21 Robot repaired in May. Reprogramming and testing starting May 3 rd 2017 Staff training: Staff had rotated since late 2015, few pharmacists have extensive operating experience. Formal operation restarted May 16 th 2017.

22 Clamp fixed May 2017 Doses Complete Failed Total May-17 Jun-17 Jul-17 Aug-17 Sep-17

23 Daily Average Doses May-17 Jun-17 Jul-17 Aug-17 Sep-17

24 FLUOROURACIL 94% DOXORUBICIN 0% CYCLOPHOSPHAMIDE 6% GEMCITABINE 0% PACLITAXEL 0%

25 25 DISCUSSION Limitations of consumables: Final containers: narrow- neck polypropylene bottles used in NTUH not compatible syringes only Syringes: 3-60 ml, may program 3 types; needs to be reprogrammed and tested if we change brands. Limitations on drug selection: Limited by vial size, width and length of vial neck, etc. Loading limitations: only 9 positions for each of syringes and vials on carousel (max. 9 orders per batch) Failure rate higher if multiple vials are needed for a single syringe.

26 26 LIMITATIONS Speed: max syringes per day Pharmacists: estimated 20 doses per hour not including dilution by manual compounding Lack of impact on manpower: 1 Pharmacy personnel needed for Order entry Printing labels and labeling Loading and loading machine Trouble shooting Waste management Above work estimated 6 person-hours (Chen et al, 2013)

27 27 LIMITATIONS Frequent dysfunctions: Very sensitive, smallest of problems may halt its process; every syringe and needle must be placed in a certain exact direction Any air drawn into syringe may cause a dose to fail Clamp positioning settings sensitive and prone to failure Residuals and waste Cost: vented needles and waste bins have to be purchased exclusively.

28 RELATED STUDIES 28 Seger AC, et al (2012): 124-bed inpatient cancer center (Dana-Farber), Before vs. after Cytocare Decreased staff safety events Improved dose accuracy Decreased cost by 56% on ancillary materials (protective equipment etc) Mean drug preparation time: increased by 47%. Labor cost, rates of severe medication error unchanged. Encountered mechanical failures that resulted in wasted medications

29 29 Seger AC, el al. J Oncol Pract 2012; 8:

30 30 Seger AC, el al. J Oncol Pract 2012; 8:

31 31 RELATED STUDIES Nurgat Z, et al (2015) Higher failure rates Encountered clamp failures and robot down time (* in chart) Nurgat Z, el al. Am J Health Sys Pharm 2015; 72:

32 32 Sessink PJM, et al. (2015) University Hospital Saint-Luc (Brussels, Belgium) doses/day Workplace contamination study Wipe testing Study drug: cyclophosphamide Simulated spill test on last study day Result: contamination mostly confined inside Cytocare. RELATED STUDIES

33 33 Simulated spill Sessink PJM, el al. J Oncol Pharm Practice 2015; 21:118-27

34 FUTURE PLANS Automation of chemotherapy is indeed safer: Less staff exposure/staff events, less contamination Better dose accuracy Workflow analysis Automation is definitely slower than manual compounding How to incorporate with best efficiency 2 may be better than 1? 1 pharmacist or technician needed to take care of Cytocare 1 person may be able to take care of 2 robots 34

35 FUTURE PLANS Lessons from Cytocare: Choice of consumables and equipment: take automation systems into consideration (syringes, final containers, needles) Choice of drugs and vial sizes: less vials per dose the better. Consider pharmacy bulk packages, vial size allowing. (NHI?) IT support: interface needed between hospital information system and operating system (Cytoplan) Entering orders by hand is too laborious and error-prone. Importance of maintenance engineers and local representatives 35

36 36 THANK YOU!

Compounding efficiency of Snap-N-Go vials compared to traditional sterile compounding techniques for vancomycin 1.5g and 2.0g

Compounding efficiency of Snap-N-Go vials compared to traditional sterile compounding techniques for vancomycin 1.5g and 2.0g 304 American Journal of Experimental and Clinical Research Original Article Compounding efficiency of Snap-N-Go vials compared to traditional sterile compounding techniques for vancomycin 1.5g and 2.0g

More information

REFERENCES American Society of Health-System Pharmacists. ASHP guidelines on handling hazardous drugs. Am J Health-Syst Pharm. 2006; 63:

REFERENCES American Society of Health-System Pharmacists. ASHP guidelines on handling hazardous drugs. Am J Health-Syst Pharm. 2006; 63: Ordering and Handling Applies To: UNM Hospitals Responsible Department: Pharmacy Revised: 8/2017 Procedure Patient Age Group: ( ) N/A (X) All Ages ( )Newborns ( )Pediatric ( )Adult DESCRIPTION/OVERVIEW

More information

Standard operating procedures for preparation and administration of intramuscular injections. No Action Rationale

Standard operating procedures for preparation and administration of intramuscular injections. No Action Rationale Standard operating procedures for preparation and administration of intramuscular injections Preparation Overview No Action Rationale 1 Collect and check all equipment 2 Check that the packaging of all

More information

Pyxis MedStation System. Guide for Managing Patient-Specific Medication

Pyxis MedStation System. Guide for Managing Patient-Specific Medication Pyxis MedStation System Guide for Managing Patient-Specific Medication April 2012 CareFusion, Pyxis, Pyxis MedStation, and the CareFusion logo are trademarks or registered trademarks of CareFusion Corporation

More information

USP 800 and Hazardous Medications

USP 800 and Hazardous Medications USP 800 and Hazardous Medications Trung H. Nguyen, PharmD and Alesha Davis, CPhT Dayton VA Medical Center Trung.Nguyen610@va.gov Alesha.Davis@va.gov The speaker has no actual or potential conflict of interest

More information

Helping to protect you from exposure to hazardous drugs

Helping to protect you from exposure to hazardous drugs Helping to protect you from exposure to hazardous drugs Closed system solution: Texium closed male luer and SmartSite needle-free valve products What you can t see can hurt you The risks are well documented

More information

Administrative Procedure

Administrative Procedure Durham Catholic District School Board The Board Title: Eyewash Stations and Safety Showers Procedure #: AP414-12 Administrative Area: Policy Reference: Human Resources and Administrative Services Emergency

More information

TexQ Decontamination Protocol. Hazardous Drugs. The Effectiveness of the. in Cleaning Surfaces Soiled with

TexQ Decontamination Protocol. Hazardous Drugs. The Effectiveness of the. in Cleaning Surfaces Soiled with by The Effectiveness of the TexQ Decontamination Protocol in Cleaning Surfaces Soiled with Hazardous Drugs Prepared by: Jay Postlewaite, Ph.D. Laura Taraban, M.D. VOLUME XV NO. 12 2.2016 The Effectiveness

More information

Sterile Product Preparation for Non-Pharmacy Personnel Dennis Sinclair, R.Ph..

Sterile Product Preparation for Non-Pharmacy Personnel Dennis Sinclair, R.Ph.. Sterile Product Preparation for Non-Pharmacy Personnel Dennis Sinclair, R.Ph.. Objectives Describe the importance of accuracy and use of proper aseptic technique when preparing IV medications. Identify

More information

Wilbert J. Fuerte, Pharm.D. PGY-1 Pharmacy Resident South Miami Hospital

Wilbert J. Fuerte, Pharm.D. PGY-1 Pharmacy Resident South Miami Hospital Implications of dose-rounding of intravenous chemotherapy at a community-based hospital Wilbert J. Fuerte, Pharm.D. PGY-1 Pharmacy Resident South Miami Hospital wilbert.fuerte@gmail.com Disclosure Statement

More information

British Columbia Cancer Agency

British Columbia Cancer Agency Page 1 of 12 A. SCOPE This Policy covers the preparation, administration, and disposal of hazardous drugs. See Cancer Drug Manual Appendix 5 for the Hazardous Drug List. (www.bccancer.bc.ca/hpi/drugdatabase/appendices)

More information

Medication management at the Valenciennes General Hospital

Medication management at the Valenciennes General Hospital Medication management at the Valenciennes General Hospital Etienne Cousein Chief Pharmacist Pharmacy Medication Department cousein-e@ch-valenciennes.fr Valenciennes General Hospital 1800 beds facility

More information

CyBio Felix Your Automated Application Starts Here

CyBio Felix Your Automated Application Starts Here Title Label Lab Automation CyBio Felix Your Automated Application Starts Here 2 CyBio FeliX Future-Proof Liquid Handling Automation Transform your manual workflows to automated processes on your benchtop!

More information

Dispensing Patient- Speci/ic Insulin. Paul Parchesky, RPh Pharmacy Manager Newport Hospital November 1, 2014

Dispensing Patient- Speci/ic Insulin. Paul Parchesky, RPh Pharmacy Manager Newport Hospital November 1, 2014 Dispensing Patient- Speci/ic Insulin Paul Parchesky, RPh Pharmacy Manager Newport Hospital November 1, 2014 Goals Background on insulin dispensing at Newport Hospital Reasons for change Purchasing pacerns

More information

Justifying New Oncology Pharmacist Positions

Justifying New Oncology Pharmacist Positions Faculty Disclosures Justifying New Oncology Pharmacist Positions I will not be discussing off-label uses of any medications I am on the speaker s bureau for Millenium Pharmaceuticals and am a paid consultant

More information

A step-by-step preparation guide

A step-by-step preparation guide A step-by-step preparation guide For needle and needle-free systems This guide provides detailed instructions on the reconstitution, dilution, and storage of VELETRI. It is intended to be used after your

More information

Intrathecal. By the end of this chapter, you will be able to: Introduction. Chapter 20

Intrathecal. By the end of this chapter, you will be able to: Introduction. Chapter 20 Chapter 20 Intrathecal Preparations By the end of this chapter, you will be able to: l Describe the specific risks with intrathecal cytotoxic products l List five checks that need to be carried out on

More information

CEPHIA Consortium for the Evaluation and Performance of HIV Incidence Assays STANDARD OPERATING PROCEDURE

CEPHIA Consortium for the Evaluation and Performance of HIV Incidence Assays STANDARD OPERATING PROCEDURE CEPHIA Consortium for the Evaluation and Performance of HIV Incidence Assays STANDARD OPERATING PROCEDURE TITLE : SOP for (off board dilution) Less Sensitive Modified VITROS Enzyme Immunoassay CEPHIA DOCUMENT

More information

Tel. : / Fax :

Tel. : / Fax : Service Best service for best customers Management BRT Corporation cares for you through reliable sales management Service Management Satisfaction Being confident of its products, BRT corporation Quality

More information

Defining, achieving, and demonstrating effective performance of containment systems. Gordon Farquharson, July 2017

Defining, achieving, and demonstrating effective performance of containment systems. Gordon Farquharson, July 2017 Defining, achieving, and demonstrating effective performance of containment systems Gordon Farquharson, July 2017 Slide 1 PharmOut 2017 Agenda Objectives and Principles. A hierarchy of containment techniques.

More information

IfAP e.v. Cologne. Current practice of cytotoxic drug preparation in German pharmacies. Cytotoxic drug preparation in German pharmacies; MEWIP-Study

IfAP e.v. Cologne. Current practice of cytotoxic drug preparation in German pharmacies. Cytotoxic drug preparation in German pharmacies; MEWIP-Study Current practice of cytotoxic drug preparation in German pharmacies MEWIP Study Institution Task Institution for Statutory Accident Insurance and Prevention in Health and Welfare Services Funding, Management

More information

Error Reduction Strategies for High-Alert Medications Kelly Besco, Pharm.D., FISMP, CPPS

Error Reduction Strategies for High-Alert Medications Kelly Besco, Pharm.D., FISMP, CPPS Error Reduction Strategies for High-Alert Medications Kelly Besco, Pharm.D., FISMP, CPPS Medication Safety Officer OhioHealth Pharmacy Services Conflict of Interest Disclosure Kelly Besco declares no conflicts

More information

SARASOTA MEMORIAL HOSPITAL

SARASOTA MEMORIAL HOSPITAL SARASOTA MEMORIAL HOSPITAL TITLE: NURSING PROCEDURE BLOOD CULTURE COLLECTION PROCEDURE (spe20) DATE: REVIEWED: PAGES: 6/10 2/19 1 of 6 PS1094 ISSUED FOR: Nursing/Lab RESPONSIBILITY: RN, LPN II, select

More information

PN Compounding Practice: The Kuwaiti Experience. Ahmed Abo-Bakr Mahmoud, R.Ph,M.Sc.,BCNSP

PN Compounding Practice: The Kuwaiti Experience. Ahmed Abo-Bakr Mahmoud, R.Ph,M.Sc.,BCNSP PN Compounding Practice: The Kuwaiti Experience Ahmed Abo-Bakr Mahmoud, R.Ph,M.Sc.,BCNSP Disclosure Information PN Compounding practice: The Kuwaiti Experience Ahmed Abo-Bakr Mahmoud I have no financial

More information

Safe. Clean. Rapid. DAC UNIVERSAL cleans, lubricates and sterilizes at the touch of a button

Safe. Clean. Rapid. DAC UNIVERSAL cleans, lubricates and sterilizes at the touch of a button CAD/CAM SYSTEMS INSTRUMENTS HYGIENE SYSTEMS TREATMENT CENTERS IMAGING SYSTEMS DAC UNIVERSAL cleans, lubricates and sterilizes at the touch of a button Safe. Clean. Rapid. DAC UNIVERSAL The hygiene formula

More information

247 CMR BOARD OF REGISTRATION IN PHARMACY

247 CMR BOARD OF REGISTRATION IN PHARMACY 247 CMR 18.00: NON-STERILE COMPOUNDING Section 18.01: Authority and Purpose 18.02: Non-Sterile Compounding Process 18.03: Non-Sterile Compounding Facility 18.04: Non-Sterile Compounding Equipment 18.05:

More information

Implementation Guide for the DoseControl Dosimetry System

Implementation Guide for the DoseControl Dosimetry System 1.0 SCOPE The GEX DoseControl System is intended for use as a single dosimetry system solution, specifically developed to satisfy the generic dosimetry needs of radiation sterilization application users

More information

Education for self administration of intravenous therapy HOME IV THERAPY. 30 minute - Baxter Pump Tobramycin

Education for self administration of intravenous therapy HOME IV THERAPY. 30 minute - Baxter Pump Tobramycin HOME IV THERAPY Tobramycin Tobramycin Check the order on the drug chart This can change when the results from your blood test come through. Your doctor will change the order, if required. A copy of the

More information

Stratis INSTRUCTIONS FOR USE. Needle-free Injection System. 0.5mL volume (+/-5%)

Stratis INSTRUCTIONS FOR USE. Needle-free Injection System. 0.5mL volume (+/-5%) Stratis Needle-free Injection System INSTRUCTIONS FOR USE 0.5mL volume (+/-5%) Stratis English Symbols Glossary (Note: All symbols are derived from ISO 15223-1, Medical Devices - Symbols to be used with

More information

Robustness Assessment of Safety Devices for Prefilled Syringes

Robustness Assessment of Safety Devices for Prefilled Syringes Robustness Assessment of Safety Devices for Prefilled Syringes INTRODUCTION Prefilled syringes are becoming a preferred way of administration with a market growth over 10% per year (1). Preferences of

More information

A step-by-step preparation guide

A step-by-step preparation guide A step-by-step preparation guide This guide provides detailed instruction on the reconstitution, dilution, and storage of Veletri (epoprostenol) for Injection. It is intended to be used after your healthcare

More information

Innovations in Administration and Injection Systems EXPERIENCED CREATIVE FOCUSED

Innovations in Administration and Injection Systems EXPERIENCED CREATIVE FOCUSED Innovations in Administration and Injection Systems EXPERIENCED CREATIVE FOCUSED Meeting Your Drug Administration Challenges Your injectable drug product will be perfectly pure when you ship it, but will

More information

Blood Glucose Monitoring System. User Guide

Blood Glucose Monitoring System. User Guide Blood Glucose Monitoring System User Guide Table of Contents Introduction...2 Important Safety Instructions...2 About ipet PRO Blood Glucose Monitoring System...3 About ipet PRO Meter...4 About the ipet

More information

Cost Analysis of Using a Closed-System Transfer Device (CSTD) for Antineoplastic Drug preparation in a Malaysian Government-Funded Hospital

Cost Analysis of Using a Closed-System Transfer Device (CSTD) for Antineoplastic Drug preparation in a Malaysian Government-Funded Hospital DOI:10.22034/APJCP.2016.17.11.4951 RESEARCH ARTICLE Cost Analysis of Using a Closed-System Transfer Device (CSTD) for Antineoplastic Drug preparation in a Malaysian Government-Funded Hospital Huan Keat

More information

Disclosures. Learning Objectives 4/26/2017

Disclosures. Learning Objectives 4/26/2017 Implementation of a quality improvement initiative to ensure the safe transition from prior-to-admission concentrated insulins to a formulary insulin regimen ERICA J. RHEIN, PHARMD PGY1 PHARMACY PRACTICE

More information

Gas Chromatography Syringe Selection Guide

Gas Chromatography Syringe Selection Guide Gas Chromatography Syringe Selection Guide Peter Morgan, Fisher, Runcorn, Cheshire, UK Technical Note 20552 Key Words Syringe selection Abstract Choosing the correct syringe from the wide selection available

More information

Pfizer, BeneFIX R2 Recombinant Factor IX

Pfizer, BeneFIX R2 Recombinant Factor IX Pfizer, BeneFIX R2 Recombinant Factor IX BeneFIX, Recombinant Factor IX, is indicated for the prevention and control of bleeding episodes in people with hemophilia B (Christmas Disease). BeneFIX is also

More information

Autopen 24 is an easy to use insulin injection pen, designed for use with 3.0ml sanofi aventis insulin cartridges. Compatible with all pen needles*.

Autopen 24 is an easy to use insulin injection pen, designed for use with 3.0ml sanofi aventis insulin cartridges. Compatible with all pen needles*. Instructions for use English Autopen 24 is an easy to use insulin injection pen, designed for use with 3.0ml sanofi aventis insulin cartridges. Compatible with all pen needles*. PLEASE FOLLOW THESE STEP-BY-STEP

More information

SECTION PRESCRIPTIONS

SECTION PRESCRIPTIONS SECTION.1800 - PRESCRIPTIONS 21 NCAC 46.1801 EXERCISE OF PROFESSIONAL JUDGMENT IN FILLING PRESCRIPTIONS (a) A pharmacist or device and medical equipment dispenser shall have a right to refuse to fill or

More information

IMPAACT MOCHA More Options for Children and Adolescents

IMPAACT MOCHA More Options for Children and Adolescents IMPAACT 2017 Phase I/II Study of the Safety, Acceptability, Tolerability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Long-Acting Injectable Rilpivirine in Virologically Suppressed

More information

Improving Patient Safety and Compliance

Improving Patient Safety and Compliance Improving Patient Safety and Compliance Module 4 Includes Recommended Procedures Table of Contents Section A... 1 A.1 Intrathecal (IT) Doses... 1 Section B... 1 B.1 Vinca Alkaloids... 1 Section C... 2

More information

6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES

6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE John Karwoski, RPh, MBA DISCLOSURE I, John Karwoski, RPH, MBA have business relationships with the companies MOBIUS THERAPEUTICS, LLC, Cubex, and

More information

Compounding Medication Regulations

Compounding Medication Regulations Association of Professors of Dermatology 2016 Annual Meeting Swissôtel, Chicago, IL Compounding Medication Regulations Christopher Bichakjian, MD Professor of Dermatology Comprehensive Cancer Center and

More information

Acknowledgement goes to WHO for use of their hand washing technique

Acknowledgement goes to WHO for use of their hand washing technique How to administer third party insulin injections safely with a pen device, safety pen needle and syringe 1 Hand washing It takes at least 15 seconds to wash your hands. This is about how long it takes

More information

Cleanroom vs. Isolator Concept Performance and cost comparison. Guy Turner, General Manager Bioquell Asia Pacific

Cleanroom vs. Isolator Concept Performance and cost comparison. Guy Turner, General Manager Bioquell Asia Pacific Cleanroom vs. Isolator Concept Performance and cost comparison Guy Turner, General Manager Bioquell Asia Pacific guy.turner@bioquell.com Slide 1 PharmOut 2017 Requirements for Sterility Testing Environment

More information

Indiana Immunization Coalition June 2013 Meeting

Indiana Immunization Coalition June 2013 Meeting Indiana Immunization Coalition June 2013 Meeting Identify 3 new recommendations for proper storage & handling of vaccines Describe the recommendations for the use of equipment used to monitor storage unit

More information

Andrew Heed, B. Pharm. CPIO, Integration Architect. The Newcastle upon Tyne Hospitals NHS Foundation Trust.

Andrew Heed, B. Pharm. CPIO, Integration Architect. The Newcastle upon Tyne Hospitals NHS Foundation Trust. Andrew Heed, B. Pharm. CPIO, Integration Architect. The Newcastle upon Tyne Hospitals NHS Foundation Trust. Afroze Mobasher, Pharm. D Analyst Configurer Imperial College Healthcare NHS Trust Local reflection

More information

The BBP Standard applies to all employers with employees with reasonably anticipated occupational exposure to blood or OPIM. It applies, not just in

The BBP Standard applies to all employers with employees with reasonably anticipated occupational exposure to blood or OPIM. It applies, not just in 1 The BBP Standard applies to all employers with employees with reasonably anticipated occupational exposure to blood or OPIM. It applies, not just in healthcare, but in general industry as well (e.g.,

More information

Model Standards for Pharmacy Compounding of Non-Sterile Preparations

Model Standards for Pharmacy Compounding of Non-Sterile Preparations Model Standards for Pharmacy Compounding of Non-Sterile Preparations Published with the Guidance Document For Pharmacy Compounding of Non-Sterile Preparations National Association of Pharmacy Regulatory

More information

2. Before Testing Monitor Checker Test...10 Inserting Lancets into Lancing Device...11 Quality Control Testing...13

2. Before Testing Monitor Checker Test...10 Inserting Lancets into Lancing Device...11 Quality Control Testing...13 Table of Contents 1. About your HemoSmart Haemoglobin Screening System Contents of Kit...4 HemoSmart Haemoglobin Meter...5 HemoSmart Haemoglobin Test Strip...7 Adjustable Lancing Device and Lancets...8

More information

Lessons learned from accidents in conventional external radiotherapy

Lessons learned from accidents in conventional external radiotherapy Lessons learned from accidents in conventional external radiotherapy Ola Holmberg 1,2, Renate Czarwinski 2 1 Radiation Protection of Patients Unit 2 Radiation Safety and Monitoring Section Division of

More information

Evidence Unit Safety Protocols in Light of Fentanyl Concerns

Evidence Unit Safety Protocols in Light of Fentanyl Concerns Evidence Unit Safety Protocols in Light of Fentanyl Concerns Robert L. Martin Manager, Evidence Unit Forensic Laboratory Services Division Seminole County Sheriff s Office Prologue By now, we have all

More information

Cigarette Smoke Generator

Cigarette Smoke Generator Sophisticated Life Science Research Instrumentation Cigarette Smoke Generator For Inhalation and Analytic Studies Info@TSE-Systems.com Contents Cigarette Smoke Generator Fully Automatic 3 Sensors 3 Cigarette

More information

Pr Pascal BONNABRY Head of pharmacy

Pr Pascal BONNABRY Head of pharmacy Hôpitaux Universitaires de Genève Evaluating the risk of aseptic preparations Pr Pascal BONNABRY Head of pharmacy Etre les premiers pour HPE Live, Birmingham vous September 9, 2014 Facts Medication errors

More information

Pharmaceutical risk management strategies for parenteral nutrition. J. Eastwood (UK)

Pharmaceutical risk management strategies for parenteral nutrition. J. Eastwood (UK) ESPEN Congress Leipzig 2013 Pharmaceutical Session Pharmaceutical risk management strategies for parenteral nutrition J. Eastwood (UK) Pharmaceutical risk management strategies for parenteral nutrition

More information

METHOTREXATE CLINICAL PRACTICE GUIDELINES FOR STAFF

METHOTREXATE CLINICAL PRACTICE GUIDELINES FOR STAFF Mary Pack Arthritis Program METHOTREXATE CLINICAL PRACTICE GUIDELINES FOR STAFF Handling of premixed injectable Methotrexate (MTX) by employees who are pregnant, breast-feeding or attempting to reproduce

More information

HOME TUBE FEEDING BASICS

HOME TUBE FEEDING BASICS HOME TUBE FEEDING BASICS UBC DIETETICS PROGRAM Module 1 of 2 SCOPE OF THESE MODULES Modules 1 & 2 address the following Nutrition Care Process steps Intervention Monitoring and Evaluation Assessment and

More information

10/27/2012. [ Safe Handling of. Hazardous Drugs. Objectives

10/27/2012. [ Safe Handling of. Hazardous Drugs. Objectives [ Safe Handling of Hazardous Drugs Objectives Discuss the history of safe handling Identify the exposure risks and routes associated with handling of hazardous drugs Review the current guidelines on the

More information

DOELAP On-Site Assessment Requirements Checklist Page 1 of 24 Participant:

DOELAP On-Site Assessment Requirements Checklist Page 1 of 24 Participant: DOELAP On-Site Assessment Requirements Checklist Page 1 of 24 General Requirements Y, N, N/A Demonstration of Conformance G.1 Latest version of protocols or procedures G.2 Latest version of dosimeter specifications

More information

Injection Solution APP 100 mg/ml MULTI-DOSE IN 1VIAL, MULTI-DOSE / 20 ml IN 1 VIAL, MULTI-DOSE

Injection Solution APP 100 mg/ml MULTI-DOSE IN 1VIAL, MULTI-DOSE / 20 ml IN 1 VIAL, MULTI-DOSE Please use the product information below as a reference when considering your answers to the following items regarding your institution s pharmacy stock of cytarabine. Product NDC Dosage Form Labeler Name

More information

Policy Title: Single-Use (Disposable) Devices Policy Number: 13. Effective Date: 6/10/2013 Review Date: 6/10/2016

Policy Title: Single-Use (Disposable) Devices Policy Number: 13. Effective Date: 6/10/2013 Review Date: 6/10/2016 Policy Title: Single-Use (Disposable) Devices Policy Number: 13 5. ROLES AND RESPONSIBILITIES: 5.1. All dental healthcare personnel have responsibility to conform and respect all aspects of this policy.

More information

SERION ELISA classic CMV Avidity Reagent B109 AVID

SERION ELISA classic CMV Avidity Reagent B109 AVID SERION ELISA classic CMV Avidity Reagent B109 AVID SERION ELISA classic Avidity Reagents are complementary components which, in combination with the corresponding SERION ELISA classic, enables the avidity

More information

Fundamentals of Flushing and Locking

Fundamentals of Flushing and Locking Fundamentals of Flushing and Locking Vascular Access Devices Fundamentals of Flushing and Locking Purpose, Product, and Process 2016 BD. BD and the BD Logo are trademarks of Becton, Dickinson and Company.

More information

Network Guidance for Handling the Spillage of Cytotoxic and Anti-Cancer Drug

Network Guidance for Handling the Spillage of Cytotoxic and Anti-Cancer Drug Network Guidance for Handling the Spillage of Cytotoxic and Anti-Cancer Drug West Midlands Expert Advisory Group for Systemic Anti-Cancer Therapy (SACT) Page 1 of 8 West Midlands Clinical Networks and

More information

Appendix 2. Adjuvant Regimens. AC doxorubin 60 mg/m 2 every 3 weeks x 4 cycles Cyclophosphamide 600 mg/m 2

Appendix 2. Adjuvant Regimens. AC doxorubin 60 mg/m 2 every 3 weeks x 4 cycles Cyclophosphamide 600 mg/m 2 Appendix 2 Adjuvant Regimens AC doxorubin 60 mg/m 2 every 3 weeks x 4 cycles Cyclophosphamide 600 mg/m 2 CMF IV cyclophosphamide 600 mg/m 2 days 1 & 8 every 4 weeks methotrexate 40 mg/m 2 for 6 cycles

More information

Reducing Waste Material and Increasing Productivity by Butt Splicing - R. Joseph Gotshall,

Reducing Waste Material and Increasing Productivity by Butt Splicing - R. Joseph Gotshall, Reducing Waste Material and Increasing Productivity by Butt Splicing - R. Joseph Gotshall, MTorres Thesis: Zero-Speed Splicing Technology can be utilized to reduce waste when splicing from one roll to

More information

3.0 POSITION ON PRE-LOADING SYRINGES WITH VACCINE

3.0 POSITION ON PRE-LOADING SYRINGES WITH VACCINE 1.0 PURPOSE 1.1 To provide guidance regarding the limited practice of pre-loading syringes with vaccine in controlled mass immunization settings as a part of a strategy to improve clinic efficiency while

More information

MAKE SMART INJECTION CHOICES INJECTION PROVIDERS GUIDE FOR SAFE INJECTIONS

MAKE SMART INJECTION CHOICES INJECTION PROVIDERS GUIDE FOR SAFE INJECTIONS MAKE SMART INJECTION CHOICES INJECTION PROVIDERS GUIDE FOR SAFE INJECTIONS MAKE SMART INJECTION CHOICES WHO recommends syringes with re-use prevention (RUP) features for all injections. RUP syringes with

More information

2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts

2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts 2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts 116 USP Update 2008 and Personnel-Related Environmental Sampling Trissel, L.A. TriPharma Research, P.O. Box 265, Cashiers,

More information

STANDARDS FOR PHARMACY COMPOUNDING OF NON-STERILE PREPARATIONS

STANDARDS FOR PHARMACY COMPOUNDING OF NON-STERILE PREPARATIONS STANDARDS FOR PHARMACY COMPOUNDING OF NON-STERILE PREPARATIONS ACKNOWLEDGEMENTS The standards in this document are based on the Model Standards for Pharmacy Compounding of Non-Sterile Preparations developed

More information

Starting Peritoneal Dialysis

Starting Peritoneal Dialysis PD Education Booklet 1 Starting Peritoneal Dialysis What you will learn: What your kidneys do Uremia (kidney disease) and its symptoms How Peritoneal Dialysis (PD) helps The two types of PD: Automated

More information

Lorazepam 2 mg vials stability

Lorazepam 2 mg vials stability Lorazepam 2 mg vials stability Search Ketalar 50 mg/ml Injection - Summary of Product Characteristics (SmPC) by Pfizer Limited. Special Issue Drug shortages: National survey reveals high level of frustration,

More information

Aseptic Process Simulation (APS) Program Risk Assessment

Aseptic Process Simulation (APS) Program Risk Assessment Aseptic Process Simulation (APS) Program Risk Assessment Angie Bragdon and Patrick Henderson Eli Lilly & Company Indianapolis Parenteral Manufacturing Agenda Background Process Case Studies Q&A 2 Background

More information

Workshop on the reprocessing of medical devices. 5. December Brussels. Nikou Ghassemieh Managing Director

Workshop on the reprocessing of medical devices. 5. December Brussels. Nikou Ghassemieh Managing Director Workshop on the reprocessing of medical devices 5. December 2008 - Brussels Nikou Ghassemieh Managing Director Established: 2003 Members from science, industry and medical practice Tasks and Goals: - Increasing

More information

Environmental Monitoring How to Satisfy the Regulator. Presented by Tanja Varglien, July 2017

Environmental Monitoring How to Satisfy the Regulator. Presented by Tanja Varglien, July 2017 Environmental Monitoring How to Satisfy the Regulator Presented by Tanja Varglien, July 2017 Slide 1 PharmOut 2017 Using Glisser You will be able to tap the download link at the end of each presentation.

More information

19/08/2014. What is Injection Safety?

19/08/2014. What is Injection Safety? Infection Prevention and Control A Foundation Course SAFE INJECTION PRACTICES AND SHARPS MANAGEMENT Fiona Barry IPCN Mercy University Hospital, Cork 2014 Links to CDC Materials http://www.youtube.com/watch%3fv%3d6d0stmoz80k

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS [Version 8, 10/2012] Cevac MD HVT_2016-October-18 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cevac MD HVT suspension and solvent for suspension for injection

More information

Reprocessing Guide. Autoclavable Arthroscope and Hardware Sterilization Tray

Reprocessing Guide. Autoclavable Arthroscope and Hardware Sterilization Tray Reprocessing Guide Autoclavable Arthroscope and Hardware Sterilization Tray 0233032116 Contents Introduction...2 Intended Use of Sterilization Trays...4 Warnings...5 Cautions...5 Instructions...6 Sterilization

More information

Altrix Precision Temperature Management System. Simple. Safe. Efficient.

Altrix Precision Temperature Management System. Simple. Safe. Efficient. Altrix Precision Temperature Management System Simple. Safe. Efficient. Altrix Precision Temperature Management System Simple. Safe. Efficient. Patient warming and cooling can be critical in achieving

More information

Glossary. ISMP Medication Safety Self Assessment for High-Alert Medications

Glossary. ISMP Medication Safety Self Assessment for High-Alert Medications Glossary Aberrant drug-related behaviors: A set of concerning behaviors in which individuals make a directed and concerted effort to obtain an opioid medication for relief of undertreated pain (pseudoaddiction),

More information

Slip on Catalyst Spill

Slip on Catalyst Spill Purpose To share lessons learned gained from incident investigations through a small group discussion method format. To understand lessons learned through a Systems of Safety viewpoint. This material was

More information

GlucCell TM SYSTEM USER S GUIDE Ver 2.1 CELL CULTURE GLUCOSE METER. Important Information. Intended Use. Caution. About the System

GlucCell TM SYSTEM USER S GUIDE Ver 2.1 CELL CULTURE GLUCOSE METER. Important Information. Intended Use. Caution. About the System GlucCell TM SYSTEM USER S GUIDE Ver 2.1 Intended Use The GlucCell TM Glucose Monitoring System (The GlucCell TM System) is designed to quantitatively measure the concentration of glucose during cell culture.

More information

Management of Central Venous Access Devices. Blood Glucose Monitoring

Management of Central Venous Access Devices. Blood Glucose Monitoring Management of Central Venous Access Devices Blood Glucose Monitoring Purpose To provide education on the standard of care regarding the use and monitoring of the Accu- Chek Blood glucose machine, including

More information

#20 Separation of Alcohols Using Gas Chromatography

#20 Separation of Alcohols Using Gas Chromatography #20 Separation of Alcohols Using Gas Chromatography Purpose: The purpose of this experiment is to determine the composition of an unknown alcohol mixture by using gas chromatography. Introduction: A gas

More information

Safe Use of Needles. Year Group: All. Document number: CSL_U02

Safe Use of Needles. Year Group: All. Document number: CSL_U02 Year Group: All Document number: CSL_U02 Equipment for this station: Needles Syringes Sharps bin Equipment list: In most situations, you will not need to recap needles but will dispose directly into a

More information

TRANSCRIPT for Lantus SoloSTAR pen injection for your patients

TRANSCRIPT for Lantus SoloSTAR pen injection for your patients TRANSCRIPT for Lantus SoloSTAR pen injection for your patients SUPER: Prescription Lantus is a long-acting insulin used to treat adults with type 2 diabetes and adults and pediatric patients (children

More information

CANCER PREVENTION AND ACCESS TO MEDICINES. Gracemarie Bricalli ESMO Head of International Affairs

CANCER PREVENTION AND ACCESS TO MEDICINES. Gracemarie Bricalli ESMO Head of International Affairs CANCER PREVENTION AND ACCESS TO MEDICINES Gracemarie Bricalli ESMO Head of International Affairs ESMO s 2020 Vision: Access to cancer care ESMO s 2020 vision statement recognises that progress in the management

More information

Hazardous Materials Medication Box and Exchange Procedure

Hazardous Materials Medication Box and Exchange Procedure September 2012 Page 1 of 6 Hazardous Materials Medication Box and Exchange Procedure EMS Service Stock 1. Each EMS Agency will be responsible for the security and storage of the supply of hazardous material

More information

Enter into the world of unprecedented accuracy! IScan D104 Series

Enter into the world of unprecedented accuracy! IScan D104 Series Enter into the world of unprecedented accuracy! IScan D104 Series 2 Three scanners, one goal: Precisely fitting restorations The D104 Series of 3D scanning systems is the 5th generation of dental scanners

More information

OtoRead Portable OAE. More Time for Care. Optimized for Accuracy and Ease of use

OtoRead Portable OAE. More Time for Care. Optimized for Accuracy and Ease of use OtoRead Portable OAE More Time for Care Optimized for Accuracy and Ease of use OtoRead simplifies your workday Based on years of experience and millions of tested ears, OtoRead offers hearing care across

More information

Intravenous Fluid and Drug Therapy

Intravenous Fluid and Drug Therapy 11 Intravenous Fluid and Drug Therapy OUTLINE Overview Direct Intravenous Injections Continuous Intravenous Injections Solution Additives Calculating IV Components as Percentages Calculating IV Flow Rates

More information

Innovations for a better world. Mixing plants. For premix and ready mix formulas.

Innovations for a better world. Mixing plants. For premix and ready mix formulas. Innovations for a better world. Mixing plants. For premix and ready mix formulas. More than a batch mixer. Integrated mixing technology from one source. Batch mixing systems from Bühler offer the perfect

More information

PORTO 2 VENT CPAP OS. Operator s Manual. PORTO 2VENT CPAP OS System Operator s Manual Part Number Rev I

PORTO 2 VENT CPAP OS. Operator s Manual. PORTO 2VENT CPAP OS System Operator s Manual Part Number Rev I PORTO 2 VENT CPAP OS Operator s Manual 1 2 TABLE of CONTENTS 1. Introduction 3. Operating Instructions 1a. Definitions 3a. Setting the CPAP Level 1b. General Description 3b. Applying the Breathing Circuit

More information

Hazardous Materials Medication Box and Exchange Procedure

Hazardous Materials Medication Box and Exchange Procedure May 2017 Page 1 of 5 Hazardous Materials Medication Box and Exchange Procedure EMS Service Stock 1. Each EMS Agency will be responsible for the security and storage of the supply of hazardous material

More information

NEEDLESTICK PREVENTION

NEEDLESTICK PREVENTION NEEDLESTICK PREVENTION Ever since the rapid increase in the number of cases of HIV/AIDS and other bloodborne infections such as hepatitis B and C, there has been tremendous interest in the healthcare community

More information

MYALEPT (MAI-uh-lept) (metreleptin) for injection for subcutaneous use

MYALEPT (MAI-uh-lept) (metreleptin) for injection for subcutaneous use .3 mg per vial _ A healthcare provider should show you how to inject MYALEPT before you use it for the first time. A healthcare provider should also watch you inject your MYALEPT dose the first time you

More information

EVER Pharma D-mine Pen Pen injector for Apomorphine 10 mg/ml

EVER Pharma D-mine Pen Pen injector for Apomorphine 10 mg/ml EVER Pharma D-mine Pen Pen injector for Apomorphine 10 mg/ml Instructions for Use with Dacepton 3 ml Cartridges Apomorphine hydrochloride hemihydrate solution for injection Subcutaneous Use TABLE OF CONTENTS

More information

BCCA PHARMACY DIRECTIVES

BCCA PHARMACY DIRECTIVES BCCA PHARMACY DIRECTIVES MODULE 4 APPENDIX 2 Table of Contents III-30-02: Blister Packed Cards for Oral Chemotherapy... 1 VI-70: Guidelines for Preparation of Parenteral Hazardous Drugs for Latex Allergy

More information

Device Preparation (all steps to be performed per standard interventional technique)

Device Preparation (all steps to be performed per standard interventional technique) sertera Biopsy Device Instructions for Use Please read all information carefully. Failure to properly follow the instructions may lead to unintended consequences. Important: This package insert is designed

More information

Laboratory Ergonomics Self- Evaluation Checklist. Standing & Sitting Benches Yes No Change/Modification Comments

Laboratory Ergonomics Self- Evaluation Checklist. Standing & Sitting Benches Yes No Change/Modification Comments Standing & Sitting Benches Yes No Change/Modification Comments 1. Is the height of the bench appropriate for the work performed? A. Work should be positioned close to elbow height (36-40 ) B. Work should

More information